These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12140731)

  • 1. The renin-angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers.
    Culman J; Blume A; Gohlke P; Unger T
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S64-70. PubMed ID: 12140731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting renin-angiotensin in the brain: the possible therapeutic implications.
    Unger T
    Blood Press Suppl; 2001; 1():12-6. PubMed ID: 11333008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of the Anti-Ischemic Effect of Angiotensin II AT( 1 ) Receptor Antagonists in the Brain.
    Saavedra JM; Benicky J; Zhou J
    Cell Mol Neurobiol; 2006; 26(7-8):1099-111. PubMed ID: 16636899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type 1 receptors in cerebral ischaemia-reperfusion: initiation of inflammation.
    Schulz R; Heusch G
    J Hypertens Suppl; 2006 Mar; 24(1):S123-9. PubMed ID: 16601565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.
    Saavedra JM
    Cell Mol Neurobiol; 2005 Jun; 25(3-4):485-512. PubMed ID: 16075377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are angiotensin receptor blockers neuroprotective?
    Thöne-Reineke C; Zimmermann M; Neumann C; Krikov M; Li J; Gerova N; Unger T
    Curr Hypertens Rep; 2004 Aug; 6(4):257-66. PubMed ID: 15257859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist.
    Ito T; Yamakawa H; Bregonzio C; Terrón JA; Falcón-Neri A; Saavedra JM
    Stroke; 2002 Sep; 33(9):2297-303. PubMed ID: 12215602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
    Li XC; Zhang J; Zhuo JL
    Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats.
    Nishimura Y; Ito T; Saavedra JM
    Stroke; 2000 Oct; 31(10):2478-86. PubMed ID: 11022082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.
    Saavedra JM; Sánchez-Lemus E; Benicky J
    Psychoneuroendocrinology; 2011 Jan; 36(1):1-18. PubMed ID: 21035950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin system and stroke.
    Marcheselli S; Micieli G
    Neurol Sci; 2008 Sep; 29 Suppl 2():S277-8. PubMed ID: 18690518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.
    Saavedra JM
    Clin Sci (Lond); 2012 Nov; 123(10):567-90. PubMed ID: 22827472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of angiotensin II receptors in stroke protection.
    Chrysant SG
    Curr Hypertens Rep; 2012 Jun; 14(3):202-8. PubMed ID: 22447068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection with angiotensin receptor antagonists: a review of the evidence and potential mechanisms.
    Wilms H; Rosenstiel P; Unger T; Deuschl G; Lucius R
    Am J Cardiovasc Drugs; 2005; 5(4):245-53. PubMed ID: 15984907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD
    Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.
    Varagic J; Ahmad S; VonCannon JL; Moniwa N; Brosnihan KB; Wysocki J; Batlle D; Ferrario CM
    Am J Hypertens; 2013 May; 26(5):583-90. PubMed ID: 23459599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathophysiological mechanisms of the renin-angiotensin system and its pharmacologic modification by ACE inhibitors or angiotensin II (type 1) receptor blockers in cardiovascular diseases].
    Huber K; Pachinger O; Pichler M; Klein W
    Z Kardiol; 1997 Apr; 86(4):239-50. PubMed ID: 9235795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-treatment with candesartan protects from cerebral ischaemia.
    Ito T; Nishimura Y; Saavedra J
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):174-9. PubMed ID: 11881119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral ischemia induced inflammatory response and altered glutaminergic function mediated through brain AT
    Justin A; Divakar S; Ramanathan M
    Biomed Pharmacother; 2018 Jun; 102():947-958. PubMed ID: 29710550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.